A phase 2, multicenter study to evaluate the efficacy and safety of autologous tumor infiltrating lymphocytes (LN-145) for the treatment of patients with recurrent and/or metastatic squamous cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback